Karim Abd-El-Maeboud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karim Abd-El-Maeboud has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Abbas A S Ghazy
1 shared publicationAbbas Ghazy
1 shared publicationAhmed El‐Bohoty
1 shared publicationAhmed Ibrahim
1 shared publicationAlaa-Eddin I Khalil
1 shared publicationAmr A-A Nadeem
1 shared publication
Latest Publications
- Open Access
- 13 August 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (8) , e104473
A Preliminary Pilot Randomized Crossover Study of Uzara (Xysmalobium undulatum) versus Ibuprofen in the Treatment of Primary Dysmenorrhea
Preliminary evaluation of efficacy and safety of uzara use in treatment of moderate and severe primary dysmenorrhea in comparison to ibuprofen. This randomized, comparative two way cross-over study comprised 60 single female students at Faculty of Medicine, Ain Shams University, Egypt, aged 19–28 years with moderate (n = 46) or severe (n = 14) primary dysmenorrhea. Participants were randomized to take either uzara (80 mg/8 hours for two doses, then 40 mg/8 hours) then ibuprofen (400 mg/6 hours) in two subsequent cycles or vice versa. The pain intensity, using VAS, was recorded immediately before taking the medication (0 hour) and after 4, 12, 24, 48–60, 96–120 hours. Main outcome measures included effectiveness of pain relief defined as drop of VAS to 3 or less, patient's global evaluation of the drug, absence from school, the use of a rescue medication, and, in those who continued the treatment, the pain intensity difference (PID) at different points after start of medication and its sum (SPID). Uzara was comparably effective to ibuprofen (78.3% vs. 86.7% of cycles; respectively), with comparable rates of effectiveness on global evaluation (being around 50% for either drug), and rates of school absences (11.7% vs. 13.3%; respectively). The need for rescue medication was different (18.3% and 10%; respectively), albeit with no statistical significance. The means of PID at different time points and SPID were comparable, with significantly lower average mean of VAS scores compared to that felt with no medication (1.6 vs. 6.8, p<0.001). Side effects were less with uzara than ibuprofen (0% vs. 8.3%, p<0.05). Uzara might be as effective as ibuprofen in management of primary dysmenorrhea but with less side effects. These findings need to be confirmed by a properly designed trial with a larger sample size. Current Controlled Trials ISRCTN25618258
- 13 August 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (8) , e104473
Open AccessA Preliminary Pilot Randomized Crossover Study of Uzara (Xysmalobium undulatum) versus Ibuprofen in the Treatment of Primary Dysmenorrhea
Preliminary evaluation of efficacy and safety of uzara use in treatment of moderate and severe primary dysmenorrhea in comparison to ibuprofen. This randomized, comparative two way cross-over study comprised 60 single female students at Faculty of Medicine, Ain Shams University, Egypt, aged 19–28 years with moderate (n = 46) or severe (n = 14) primary dysmenorrhea. Participants were randomized to take either uzara (80 mg/8 hours for two doses, then 40 mg/8 hours) then ibuprofen (400 mg/6 hours) in two subsequent cycles or vice versa. The pain intensity, using VAS, was recorded immediately before taking the medication (0 hour) and after 4, 12, 24, 48–60, 96–120 hours. Main outcome measures included effectiveness of pain relief defined as drop of VAS to 3 or less, patient's global evaluation of the drug, absence from school, the use of a rescue medication, and, in those who continued the treatment, the pain intensity difference (PID) at different points after start of medication and its sum (SPID). Uzara was comparably effective to ibuprofen (78.3% vs. 86.7% of cycles; respectively), with comparable rates of effectiveness on global evaluation (being around 50% for either drug), and rates of school absences (11.7% vs. 13.3%; respectively). The need for rescue medication was different (18.3% and 10%; respectively), albeit with no statistical significance. The means of PID at different time points and SPID were comparable, with significantly lower average mean of VAS scores compared to that felt with no medication (1.6 vs. 6.8, p<0.001). Side effects were less with uzara than ibuprofen (0% vs. 8.3%, p<0.05). Uzara might be as effective as ibuprofen in management of primary dysmenorrhea but with less side effects. These findings need to be confirmed by a properly designed trial with a larger sample size. Current Controlled Trials ISRCTN25618258
- Open Access
- 18 January 2013
- Published by Springer Nature
Vaginal application of acetic acid 3% gel to hasten induction of abortion in women with mid-trimestric missed abortion
- 18 January 2013
- Published by Springer Nature
Open AccessVaginal application of acetic acid 3% gel to hasten induction of abortion in women with mid-trimestric missed abortion
- Open Access
- 6 December 2012
- Published by Springer Nature
Gum chewing and the return of bowel motility after caesarean section under regional anaesthesia
- 6 December 2012
- Published by Springer Nature
Open AccessGum chewing and the return of bowel motility after caesarean section under regional anaesthesia
- 12 September 2012
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 119 (3) , 248-252
Vaginal acidity enhancement with a 3% acetic acid gel prior to misoprostol treatment for pregnancy termination in the midtrimester
To investigate whether enhancing vaginal acidity improves the success of medical abortions in the midtrimester. A double-blind, randomized, placebo-controlled trial was conducted with 48 women with missed midtrimester abortions. Twice daily, the study participants (n=24) were treated with a 3% acetic acid gel and the controls (n=24) with a placebo gel, starting 2 days prior to initiating the misoprostol treatment. The primary outcome measures were the rates of successful abortion within 24 and 48 hours. Secondary measures included gel tolerability and adverse effects of the misoprostol treatment. The success rates were higher in the study group, within both 24 hours (11/23 vs 3/24; P=0.011) and 48 hours (18/23 vs 6/24; P<0.001). Among the women with a vaginal pH of 5 or higher at baseline, acidic gel was also associated with higher success rates within 24 hours (8/13 vs 2/15; P<0.01) and 48 hours (13/13 vs 3/15; P<0,001). The vaginal gels were well tolerated and the misoprostol treatment produced no serious adverse effects. A 3% acetic acid gel appears to be an effective and safe preparatory adjuvant to vaginal misoprostol treatment for midtrimester medical abortions, especially in women with a vaginal pH of 5 or higher. www.controlledtrials.com: ISRCTN75746444.
- 12 September 2012
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 119 (3) , 248-252
Vaginal acidity enhancement with a 3% acetic acid gel prior to misoprostol treatment for pregnancy termination in the midtrimester
To investigate whether enhancing vaginal acidity improves the success of medical abortions in the midtrimester. A double-blind, randomized, placebo-controlled trial was conducted with 48 women with missed midtrimester abortions. Twice daily, the study participants (n=24) were treated with a 3% acetic acid gel and the controls (n=24) with a placebo gel, starting 2 days prior to initiating the misoprostol treatment. The primary outcome measures were the rates of successful abortion within 24 and 48 hours. Secondary measures included gel tolerability and adverse effects of the misoprostol treatment. The success rates were higher in the study group, within both 24 hours (11/23 vs 3/24; P=0.011) and 48 hours (18/23 vs 6/24; P<0.001). Among the women with a vaginal pH of 5 or higher at baseline, acidic gel was also associated with higher success rates within 24 hours (8/13 vs 2/15; P<0.01) and 48 hours (13/13 vs 3/15; P<0,001). The vaginal gels were well tolerated and the misoprostol treatment produced no serious adverse effects. A 3% acetic acid gel appears to be an effective and safe preparatory adjuvant to vaginal misoprostol treatment for midtrimester medical abortions, especially in women with a vaginal pH of 5 or higher. www.controlledtrials.com: ISRCTN75746444.
- 10 August 2009
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 116 (10) , 1334-1339
Gum chewing stimulates early return of bowel motility after caesarean section
To evaluate the efficacy and safety of postoperative gum chewing on the recovery of bowel motility after caesarean section. A randomised controlled study. Faculty of Medicine, Ain Shams University, Egypt. A total of 200 pregnant women delivered by elective caesarean section (CS) under general anaesthesia. Women were randomised into two groups; group A (93 women) who received one stick of sugarless gum for 15 minutes every 2 hours after surgery, and group B (107 women) had traditional management (oral intake of clear fluids allowed after passage of flatus and regular diet with the passage of bowel movement). Time to first hearing of normal intestinal sounds, time to first flatus, time to first bowel movement and length of hospital stay. The mean duration of surgery was longer in group A (41.3 +/- 7.5 versus 38.4 +/- 8.1 minutes, P < 0.05). The mean postoperative time interval to first hearing of normal intestinal sounds (10.9 +/- 2.7 versus 15.6 +/- 3.7 hours), passage of flatus (17.9 +/- 4.6 versus 24.4 +/- 7.1 hours), defecation (21.1 +/- 4.7 versus 30 +/- 8.2 hours) and discharge from the hospital (40.8 +/- 10.6 versus 50.5 +/- 8.9 hours) were significantly shorter in group A (P < 0.001). Severe ileus occurred only in one woman belonging to group B. All patients in group A tolerated gum chewing beginning on the first postoperative day. Gum chewing after CS is safe, well tolerated, and associated with rapid resumption of intestinal motility and shorter hospital stay; with potential impact on reducing the overall healthcare costs in case of routine implementation.
- 10 August 2009
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 116 (10) , 1334-1339
Gum chewing stimulates early return of bowel motility after caesarean section
To evaluate the efficacy and safety of postoperative gum chewing on the recovery of bowel motility after caesarean section. A randomised controlled study. Faculty of Medicine, Ain Shams University, Egypt. A total of 200 pregnant women delivered by elective caesarean section (CS) under general anaesthesia. Women were randomised into two groups; group A (93 women) who received one stick of sugarless gum for 15 minutes every 2 hours after surgery, and group B (107 women) had traditional management (oral intake of clear fluids allowed after passage of flatus and regular diet with the passage of bowel movement). Time to first hearing of normal intestinal sounds, time to first flatus, time to first bowel movement and length of hospital stay. The mean duration of surgery was longer in group A (41.3 +/- 7.5 versus 38.4 +/- 8.1 minutes, P < 0.05). The mean postoperative time interval to first hearing of normal intestinal sounds (10.9 +/- 2.7 versus 15.6 +/- 3.7 hours), passage of flatus (17.9 +/- 4.6 versus 24.4 +/- 7.1 hours), defecation (21.1 +/- 4.7 versus 30 +/- 8.2 hours) and discharge from the hospital (40.8 +/- 10.6 versus 50.5 +/- 8.9 hours) were significantly shorter in group A (P < 0.001). Severe ileus occurred only in one woman belonging to group B. All patients in group A tolerated gum chewing beginning on the first postoperative day. Gum chewing after CS is safe, well tolerated, and associated with rapid resumption of intestinal motility and shorter hospital stay; with potential impact on reducing the overall healthcare costs in case of routine implementation.
- 1 November 2007
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 34 (1) , 78-84
Effect of vaginal pH on the efficacy of vaginal misoprostol for induction of midtrimester abortion
Aim: To evaluate the effect of vaginal pH on the efficacy of misoprostol for induction of midtrimester abortion.Methods: The study comprised 110 women, with a gestational age of 14–26 weeks, with a missed abortion as an indication for the induction of abortion. On admission, the vaginal pH was measured and two groups were generated: (A) those with pH < 5 (n = 63); and (B) those with pH ≥ 5 (n = 47). All of the women received intravaginal misoprostol tablets moistened with 3 mL of 5% acetic acid, 200 μg every 4 h for a maximum of 5 doses within 24 h. If the patient did not have adequate uterine contractions, the same regimen was repeated over the following 24 h and if no response was achieved, this was considered a failure of therapy.Results: All patients aborted within 48 h. A significant positive correlation between vaginal pH and the misoprostol application‐abortion interval was found. The mean induction‐abortion interval was significantly shorter in group A compared to group B (12.1 vs 23.6 h, P < 0.001), with abortion rates at 24 h being 100% and 63.8%, respectively. Moreover, a significantly lower dose of misoprostol was used in group A with a lower incidence of fever and abdominal pain.Conclusion: Vaginal pH influences the efficacy of misoprostol administered vaginally for the induction of midtrimester abortion. The presence of this relationship, despite premoistening misoprostol with an acidifying agent, suggests that the effect of vaginal pH might extend beyond affecting the pharmacokinetics of the drug.
- 1 November 2007
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 34 (1) , 78-84
Effect of vaginal pH on the efficacy of vaginal misoprostol for induction of midtrimester abortion
Aim: To evaluate the effect of vaginal pH on the efficacy of misoprostol for induction of midtrimester abortion.Methods: The study comprised 110 women, with a gestational age of 14–26 weeks, with a missed abortion as an indication for the induction of abortion. On admission, the vaginal pH was measured and two groups were generated: (A) those with pH < 5 (n = 63); and (B) those with pH ≥ 5 (n = 47). All of the women received intravaginal misoprostol tablets moistened with 3 mL of 5% acetic acid, 200 μg every 4 h for a maximum of 5 doses within 24 h. If the patient did not have adequate uterine contractions, the same regimen was repeated over the following 24 h and if no response was achieved, this was considered a failure of therapy.Results: All patients aborted within 48 h. A significant positive correlation between vaginal pH and the misoprostol application‐abortion interval was found. The mean induction‐abortion interval was significantly shorter in group A compared to group B (12.1 vs 23.6 h, P < 0.001), with abortion rates at 24 h being 100% and 63.8%, respectively. Moreover, a significantly lower dose of misoprostol was used in group A with a lower incidence of fever and abdominal pain.Conclusion: Vaginal pH influences the efficacy of misoprostol administered vaginally for the induction of midtrimester abortion. The presence of this relationship, despite premoistening misoprostol with an acidifying agent, suggests that the effect of vaginal pH might extend beyond affecting the pharmacokinetics of the drug.